A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer

Michael A. Carducci, Fred Saad, Per Anders Abrahamsson, David P. Dearnaley, Claude C. Schulman, Scott A. North, Darryl J. Sleep, Jeffrey D. Isaacson, Joel B. Nelson

Research output: Contribution to journal › Article › peer-review

258 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences